Skip to main content
. 2019 Nov 8;12:106. doi: 10.1186/s13048-019-0580-7

Fig. 9.

Fig. 9

Overall survival analysis of MCM3 and GINS2 expression with prognosis of ovarian cancer patients. The patients with ovarian cancer were divided into two groups (high vs. low), according to the median expression level of MCM3 and GINS2